RACGAP1P, as a competitive endogenous RNA (ceRNA), is reported to be upregulated in hepatocellular carcinoma, resulting in the activation of the RACGAP1/RhoA/ERK pathway by the inhibition of miR-15-5p interference on RACGAP1 expression. Here, RHOA is linked to hepatocellular carcinoma.